Screener
Mirum Pharmaceuticals, Inc. MIRM Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
FAQ
- What is Mirum Pharmaceuticals, Inc.'s total liabilities?
- Mirum Pharmaceuticals, Inc. (MIRM) reported total liabilities of $1.06B in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s total liabilities changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s total liabilities increased by 124.2% year-over-year, from $470.67M to $1.06B.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s total liabilities has grown at a 50.3% compound annual growth rate (CAGR), from $68.77M to $528.12M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Mirum Pharmaceuticals, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude